Aromatase inhibitors are a class of medications that block the enzyme aromatase, which is responsible for converting androgens into estrogen. These drugs are commonly used in the treatment of hormone-sensitive breast cancer as they lower estrogen levels in the body, thereby slowing down the growth of estrogen-receptor-positive tumors.
There are three main types of aromatase inhibitors – nonsteroidal (such as anastrozole and letrozole) and steroidal (exemestane). While they work in slightly different ways, all three types effectively lower estrogen levels either by blocking aromatase or by binding to aromatase and rendering it inactive.
Aromatase inhibitors are typically prescribed for postmenopausal women with hormone-sensitive breast cancer, either alone or in combination with other treatments like surgery, chemotherapy, or radiation therapy. They may also be used preventively in women at high risk of developing breast cancer or to treat other conditions such as endometriosis or gynecomastia in men.
Like all medications, aromatase inhibitors can have side effects, including joint pain, hot flashes, osteoporosis, and increased risk of cardiovascular disease. However, for many patients, the benefits of reducing estrogen levels and slowing down tumor growth outweigh the potential risks.
Check out the catalog of drugs with the active ingredient Aromatase inhibitors on the https://buysteroidsgroup.net/aromatase-inhibitors/ website. Affordable prices, wide selection.
Conclusion
In conclusion, the dosage of aromatase inhibitors plays a crucial role in effectively managing hormone receptor-positive breast cancer. It is important for healthcare providers to carefully consider the appropriate dosage based on individual patient factors and monitor for potential side effects throughout treatment.